SE436208B - Sett att framstella 5-fluoro-uracilderivat - Google Patents

Sett att framstella 5-fluoro-uracilderivat

Info

Publication number
SE436208B
SE436208B SE7714670A SE7714670A SE436208B SE 436208 B SE436208 B SE 436208B SE 7714670 A SE7714670 A SE 7714670A SE 7714670 A SE7714670 A SE 7714670A SE 436208 B SE436208 B SE 436208B
Authority
SE
Sweden
Prior art keywords
compound
fluoro
administered
fluorouracil
control
Prior art date
Application number
SE7714670A
Other languages
English (en)
Swedish (sv)
Other versions
SE7714670L (sv
Inventor
S Kijima
H Shionoya
K Hamamura
H Arai
N Koyanagi
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of SE7714670L publication Critical patent/SE7714670L/
Publication of SE436208B publication Critical patent/SE436208B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SE7714670A 1976-12-24 1977-12-22 Sett att framstella 5-fluoro-uracilderivat SE436208B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51154941A JPS6052708B2 (ja) 1976-12-24 1976-12-24 ５−フルオロウラシル系化合物およびそれを含有する抗腫瘍剤

Publications (2)

Publication Number Publication Date
SE7714670L SE7714670L (sv) 1978-06-25
SE436208B true SE436208B (sv) 1984-11-19

Family

ID=15595270

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7714670A SE436208B (sv) 1976-12-24 1977-12-22 Sett att framstella 5-fluoro-uracilderivat

Country Status (14)

Country Link
US (1) US4130648A (fr)
JP (1) JPS6052708B2 (fr)
AU (1) AU519524B2 (fr)
BE (1) BE862213A (fr)
CA (1) CA1077483A (fr)
CH (1) CH636874A5 (fr)
DE (1) DE2757431A1 (fr)
ES (1) ES465406A1 (fr)
FR (1) FR2378779A1 (fr)
GB (1) GB1594840A (fr)
NL (1) NL7714205A (fr)
PH (1) PH12700A (fr)
SE (1) SE436208B (fr)
SU (2) SU827489A1 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU1235864A1 (ru) * 1983-03-11 1986-06-07 Отделение ордена Ленина института химической физики АН СССР Нитроксильные производные 5-фторурацила,обладающие противоопухолевой активностью
US4727077A (en) * 1985-02-20 1988-02-23 Ishihara Sangyo Kaisha Ltd. Benzoyl urea compounds, process for their production, and antitumorous compositions containing them
DK197486A (da) * 1986-04-30 1987-10-31 Ferring Farma Lab 5-fluoruracilprodug
US11034667B2 (en) 2017-01-09 2021-06-15 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
US11584733B2 (en) 2017-01-09 2023-02-21 Shuttle Pharmaceuticals, Inc. Selective histone deacetylase inhibitors for the treatment of human disease
CA3087565A1 (fr) 2018-01-09 2019-07-18 Shuttle Pharmaceuticals, Inc. Inhibiteurs selectifs d'histone deacetylase pour le traitement d'une maladie humaine

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5324952B2 (fr) * 1973-11-28 1978-07-24

Also Published As

Publication number Publication date
AU3182577A (en) 1979-06-28
JPS6052708B2 (ja) 1985-11-20
SE7714670L (sv) 1978-06-25
JPS5379880A (en) 1978-07-14
FR2378779B1 (fr) 1980-08-22
SU795469A3 (ru) 1981-01-07
US4130648A (en) 1978-12-19
NL7714205A (nl) 1978-06-27
CA1077483A (fr) 1980-05-13
GB1594840A (en) 1981-08-05
DE2757431A1 (de) 1978-06-29
CH636874A5 (de) 1983-06-30
ES465406A1 (es) 1978-09-16
SU827489A1 (ru) 1981-05-07
PH12700A (en) 1979-07-20
FR2378779A1 (fr) 1978-08-25
BE862213A (fr) 1978-04-14
AU519524B2 (en) 1981-12-10

Similar Documents

Publication Publication Date Title
EP0219936B1 (fr) Complexes de platine
KR100442096B1 (ko) 이중 디카르복실산 디아미노플라틴 착체의 항종양 유도체, 그의 제조방법, 그것을 함유하는 약학조성물 및 그 유도체의 적용
KR840001965B1 (ko) 안트라센-9,10-비스-카르보닐-히드라존 유도체 제조방법
RU2324688C2 (ru) Производные бисбензизоселеназолонила с противоопухолевым, противовоспалительным и антитромботическим действием и их применение
EP0282672B1 (fr) Complexes de platine
EP0191096B1 (fr) Compositions de ruthenium a effet inhibiteur de tumeurs
SE436208B (sv) Sett att framstella 5-fluoro-uracilderivat
EP0563386A1 (fr) Composition anticancereuse et compose
US11440916B2 (en) Selective A2A receptor antagonist
EP0214862B1 (fr) Complexes de platine antitumeur, leur préparation et leur utilisation
JP2004505899A (ja) ５’−デオキシ−ｎ−（置換されたオキシカルボニル）−５−フルオロシトシン及びその誘導体、その製造方法、並びに、これを有効性分として含む抗癌剤組成物
JPS63264580A (ja) ３−（２−ハロアルキル）−１，４−オキサチインおよび２−（２−ハロアルキル）−１，４−ジチイン
US5214174A (en) Platinum complex and anti-tumor agent comprising said complex as active ingredient
JPH04264092A (ja) シクロトリホスファゼンのｎ，ｏスピロ環状誘導体とその製法および用途
EP0087951B1 (fr) Dérivés de la phenanthroline
WO1994006781A1 (fr) Nouveaux composes de traitement du cancer
KR100398289B1 (ko) 신규 안트라사이클린 유도체 및 그 제조방법
JPS6125707B2 (fr)
JPS645597B2 (fr)
JPS59210017A (ja) 抗腫瘍剤
JPH0120128B2 (fr)
KR940010298B1 (ko) 신규한 플라티늄(ii) 착화합물과 그의 제조방법
SE449105B (sv) 13-/1-oxyl-2,2,6,6-tetrametylpiperyldenyl-4/-rubomycinhydrazon hydroklorid samt forfarande for dess framstellning
JPS6310712B2 (fr)
JPH01313425A (ja) 糖ラクタム誘導体及びそれを含有する癌細胞転移抑制剤

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7714670-2

Effective date: 19880927

Format of ref document f/p: F